|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Berlex Inc., of Wayne, N.J., initiated a voluntary nationwide recall of a single lot (No. 41500A) of its intravenous X-ray contrast agent, Ultravist injection 370 mgI/mL, 125 mL, (iopromide injection) due to the presence of particulate matter in conjunction with crystallization. The company, which received two complaints of vials that exhibited crystallization, said the recall is "in consideration of the potential for serious safety problems," such as thrombosis of blood vessels, thromboembolism and injury or infarction of end organs such as heart, kidney and brain. An investigation is ongoing to determine whether any other lots might be affected.
o CytoDyn ...
Related newspaper, magazine, and journal articles:
|
|
Article: Micromet, Inc. Reports Fourth Quarter and Full Year 2006 ...
PR Newswire Europe;
March 16, 2007 ;
700+ words
... ... California, March 16 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI) ( Micromet or the Company ), a biopharmaceutical company ... As a result of the reverse merger between Micromet AG and CancerVax Corporation that was completed ...
|
|